References
1. World Health Organization International Collaborative Study of Hypertensive Disorders of
Pregnancy (1988). Geographic variation in the incidence of hypertension in pregnancy. Am J
Obstet Gynecol, 158(1):80-3.
2. Department of Health. (1996) Confidential Enquiry into stillbirths and deaths in infancy.
London: Department of Health.
3. Rosenberg K, Twaddle S. (1990) Screening and surveillance of pregnancy hypertension – an
economic approach to the use of daycare. Bailliere’s Clin Obstetrics and Gynaecology, 4:89-107.
4. Anthony J. (1992) Improving antenatal care: the role of the antenatal assessment unit. Health
Trends; 24:123-5
5. Bouvier-Colle MH, Salanave B, Ancel PY (1996) Obstetric patients treated in intensive care
units and maternal mortality. European journal of Obstetric and Gynaecological Reproductive
Biology. 65:121-5
6. Douglas KA, Redman CW. (1994) Eclampsia in the United Kingdom. BMJ; 309(6966):1395400.
7. The National Institute for Clinical Excellence, The Scottish Executive Health Department, The
Department of Health and Social Services and Public Safety Northern Ireland. Why Mothers Die
1997-1999:the fifth report of the Confidential Enquiries into Maternal Deaths in the United
Kingdom. London: RCOG Press, 2001
8. Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their
babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled
trial. Lancet 2002; 359(9321):1877-90.
9. The Magpie Trial Follow-up Study Collaborative Group. (2007)The Magpie Trial: a randomised
trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18
months. BJOG 114 (3) 289-299.
10. The Magpie Trial Follow-up Study Collaborative Group. (2007) The Magpie Trial: a
randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for
women at two years. BJOG 114 (3) 300-309.
11. Magpie Trial Follow Up Study Collaborative Group. The Magpie Trial Follow Up Study:
outcome after discharge from hospital for women and children recruited to a trial comparing
magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761]. BMC Pregnancy and
Childbirth 2004; 4(5).
12. Farrell B, Duley L (2007) Doing the undoable: Magpie Trial long-tem follow-up. The Lancet;
369(9555): 13-14
13. Squires J, Potter L, Bricker D. The ASQ user's guide for the Ages and Stages Questionnaires:
a parent-completed, child monitoring system. 2nd edition. Baltimore: Paul Brookes Publishing Co,
1999.
14. Smyth RMD, Duley L, Jacoby A, Elbourne D. Women’s experiences of participating in the
Magpie Trial: a UK survey by postal questionnaire. Birth (in press)
15. Bayley N. Manual for the Bayley scales of infant development. 2nd edition. New York:
Psychological Corporation, 1993.
2
16. Fooks J, Mutch L, Yudkin P, Johnson A, Elbourne D. Comparing two methods of follow up in
a Multicentre randomised trial. Arch Dis Child 76: 369-367
17. Glazener C, Abdalla M, Stroud P et al. Postnatal maternal morbidity: extent, causes,
prevention and treatment. BJOG 1995; 102: 282-7
18. Brown S Lumley J. Physical health problems after childbirth and maternal depression at six to
seven months postpartum BJOG 2000; vol 107 (10): 1194-1200
19. Murray L, Cooper PJ Effects of postnatal depression on infant development Arch.Dis.Child
1997; 77:99-101
20. Cooper PJ, Murray L Postnatal depression BMJ 1998:; 316: 1884-1886
21. Petterson SM, Burke Albers. A Affects of poverty and maternal depression on early child
development. Child Development 2001; vol 72 (6): 1194-1813
22. Dawson G, Ashman S et al. Preschool outcomes of children with depressed mothers Child
Development 2000; vol 74 (4): 1158-75
3